Header Logo

Aniket Kawatkar

Concepts (144)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
5
2015
23
1.470
Why?
Managed Care Programs
6
2017
325
1.170
Why?
Health Expenditures
3
2014
76
0.900
Why?
Diverticulitis, Colonic
2
2014
8
0.890
Why?
Emergency Service, Hospital
4
2021
368
0.630
Why?
Middle Aged
20
2021
8020
0.620
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2018
40
0.580
Why?
Data Collection
3
2014
257
0.570
Why?
Febrile Neutropenia
1
2017
3
0.560
Why?
Algorithms
2
2020
239
0.560
Why?
Attention Deficit Disorder with Hyperactivity
2
2014
64
0.540
Why?
Antirheumatic Agents
3
2015
11
0.540
Why?
Retrospective Studies
12
2021
2467
0.540
Why?
Adrenergic beta-2 Receptor Agonists
1
2015
6
0.510
Why?
Asthma
2
2016
387
0.510
Why?
Aged
17
2021
6173
0.500
Why?
Male
19
2021
10145
0.500
Why?
Female
19
2021
12780
0.480
Why?
Tomography, X-Ray Computed
2
2014
211
0.480
Why?
Diverticulitis
1
2014
2
0.470
Why?
Humans
22
2021
17822
0.460
Why?
Electronic Health Records
3
2020
698
0.460
Why?
Inpatients
1
2014
81
0.450
Why?
Outpatients
1
2014
110
0.440
Why?
Consumer Behavior
2
2004
29
0.440
Why?
Health Care Costs
1
2015
229
0.430
Why?
Mental Health
1
2014
166
0.410
Why?
Ambulatory Care
1
2014
247
0.410
Why?
Young Adult
8
2015
2464
0.410
Why?
Adolescent
9
2015
3690
0.400
Why?
Self Report
1
2014
253
0.390
Why?
Adult
12
2016
7708
0.370
Why?
Severity of Illness Index
1
2012
455
0.360
Why?
Acute Coronary Syndrome
2
2021
18
0.350
Why?
Patient Acceptance of Health Care
1
2014
391
0.350
Why?
Breast Neoplasms
1
2018
957
0.340
Why?
California
9
2019
2328
0.340
Why?
Acute Disease
3
2014
144
0.330
Why?
Aged, 80 and over
7
2019
1931
0.320
Why?
Comorbidity
4
2015
597
0.320
Why?
Urinary Bladder Neoplasms
2
2019
56
0.310
Why?
Cohort Studies
6
2020
2590
0.280
Why?
Cost-Benefit Analysis
2
2020
250
0.250
Why?
United States
6
2015
4007
0.250
Why?
Drug Information Services
1
2004
3
0.230
Why?
Drug Industry
1
2004
4
0.230
Why?
Formularies as Topic
1
2004
2
0.230
Why?
Leukocytosis
2
2014
5
0.220
Why?
Advertising as Topic
1
2004
23
0.220
Why?
Abdominal Pain
2
2014
15
0.220
Why?
Insurance, Pharmaceutical Services
1
2004
25
0.220
Why?
Predictive Value of Tests
2
2014
354
0.220
Why?
Fever
2
2014
55
0.220
Why?
Treatment Outcome
3
2018
1265
0.220
Why?
Critical Pathways
1
2021
11
0.180
Why?
Odds Ratio
4
2015
673
0.180
Why?
Sex Factors
3
2021
644
0.180
Why?
Radiotherapy, Intensity-Modulated
1
2020
2
0.170
Why?
Tonsillar Neoplasms
1
2020
2
0.170
Why?
Robotic Surgical Procedures
1
2020
6
0.170
Why?
Exercise Test
1
2020
45
0.170
Why?
Urinary Bladder
1
2019
9
0.170
Why?
Hospitalization
2
2017
810
0.160
Why?
BCG Vaccine
1
2019
7
0.160
Why?
Adjuvants, Immunologic
1
2019
16
0.160
Why?
Carcinoma, Squamous Cell
1
2020
55
0.160
Why?
Antineoplastic Agents
1
2019
59
0.160
Why?
Cardiovascular Diseases
2
2015
599
0.160
Why?
Recurrence
2
2016
189
0.150
Why?
Incidence
3
2017
1269
0.150
Why?
Risk Assessment
2
2021
1103
0.150
Why?
Mastectomy, Segmental
1
2018
20
0.150
Why?
Disease Progression
2
2016
267
0.150
Why?
Health Status Disparities
1
2019
147
0.150
Why?
Mastectomy
1
2018
36
0.150
Why?
Logistic Models
3
2015
928
0.150
Why?
Comparative Effectiveness Research
1
2018
66
0.140
Why?
Blood Cells
1
2016
4
0.140
Why?
Eosinophils
1
2016
9
0.140
Why?
Quality of Health Care
1
2019
326
0.130
Why?
Age Factors
2
2019
923
0.130
Why?
Delivery of Health Care, Integrated
3
2019
537
0.130
Why?
Population Surveillance
2
2015
264
0.130
Why?
Multivariate Analysis
2
2014
569
0.130
Why?
Registries
1
2018
472
0.120
Why?
Medication Adherence
2
2015
246
0.120
Why?
Etanercept
1
2015
4
0.120
Why?
International Classification of Diseases
1
2015
85
0.120
Why?
Adalimumab
1
2015
5
0.120
Why?
Hip Fractures
1
2015
70
0.120
Why?
Pilot Projects
1
2014
219
0.110
Why?
Patient Preference
1
2014
48
0.110
Why?
Dopamine Uptake Inhibitors
1
2013
4
0.110
Why?
Bupropion
1
2013
12
0.110
Why?
Quinoxalines
1
2013
12
0.110
Why?
Sentinel Surveillance
1
2013
12
0.110
Why?
Nicotinic Agonists
1
2013
26
0.110
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2015
172
0.110
Why?
Benzazepines
1
2013
24
0.110
Why?
Economics, Pharmaceutical
1
2012
2
0.100
Why?
Home Care Agencies
1
2012
2
0.100
Why?
Abscess
1
2012
6
0.100
Why?
Prognosis
1
2014
609
0.100
Why?
Continental Population Groups
1
2014
302
0.100
Why?
Product Surveillance, Postmarketing
1
2013
95
0.100
Why?
Drug Costs
1
2012
34
0.100
Why?
Office Visits
1
2012
80
0.100
Why?
Ethnic Groups
1
2015
485
0.100
Why?
Smoking Cessation
1
2013
193
0.090
Why?
Models, Statistical
1
2012
178
0.090
Why?
Socioeconomic Factors
1
2012
630
0.090
Why?
Risk Factors
2
2014
3362
0.090
Why?
United States Food and Drug Administration
2
2013
34
0.080
Why?
Time Factors
1
2012
1097
0.080
Why?
Neoplasm Staging
2
2020
330
0.080
Why?
Hispanic Americans
2
2019
404
0.060
Why?
European Continental Ancestry Group
2
2019
529
0.060
Why?
Periodicals as Topic
1
2004
14
0.060
Why?
Texas
1
2004
35
0.060
Why?
Guidelines as Topic
1
2004
40
0.060
Why?
Attitude
1
2004
30
0.050
Why?
African Americans
2
2019
472
0.050
Why?
Health Services Research
1
2004
232
0.050
Why?
Follow-Up Studies
2
2016
1219
0.050
Why?
Markov Chains
1
2020
23
0.040
Why?
Cross-Sectional Studies
1
2004
1335
0.040
Why?
Administration, Intravesical
1
2019
2
0.040
Why?
Neoplasm Invasiveness
1
2019
78
0.040
Why?
Sensitivity and Specificity
1
2020
305
0.040
Why?
Natural Language Processing
1
2020
58
0.040
Why?
Cell Count
1
2016
10
0.030
Why?
Practice Patterns, Physicians'
1
2019
332
0.030
Why?
Anti-Asthmatic Agents
1
2016
85
0.030
Why?
Biomarkers
1
2016
310
0.030
Why?
Dose-Response Relationship, Drug
1
2015
129
0.030
Why?
Risk
1
2015
518
0.030
Why?
Varenicline
1
2013
13
0.030
Why?
Health Behavior
1
2015
360
0.030
Why?
Tobacco Use Disorder
1
2013
49
0.030
Why?
Prospective Studies
1
2016
1286
0.030
Why?
Case-Control Studies
1
2015
1120
0.030
Why?
Drug Prescriptions
1
2013
151
0.020
Why?
Medicaid
1
2013
190
0.020
Why?
Prevalence
1
2014
888
0.020
Why?
Concepts (144)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente